中国上市医药企业知识产权管理绩效评价研究

发布时间：2018-03-08 08:38

本文选题：上市医药企业　切入点：知识产权管理　出处：《辽宁大学》2017年硕士论文　论文类型：学位论文

【摘要】：知识经济日益发展,知识产权已经成为经济全球化大背景下企业竞争的关键所在。各大企业为了更好地融入到全球化中,提高企业的核心竞争力以应对激烈的市场竞争,提高企业自身的知识产权管理水平已成为当务之急。本文基于我国医药企业知识产权的具体特征,结合相关理论研究,一方面,有针对性地把握知识产权、知识产权管理以及医药企业这三者之间的关系;另一方面,从知识产权管理全过程的视角出发,建立了针对我国医药企业的知识产权管理绩效评价指标体系;在此基础上,采用模糊综合评价法构建模型。更进一步选取我国上市医药样本企业进行实证评价。本文旨在对我国医药企业知识产权管理绩效的评价提供科学可操作的方法,并对完善我国医药企业知识产权管理工作提出合理的意见和建议,以期促进我国医药企业的可持续发展。(1)本文在对知识产权、企业知识产权管理、绩效评价相关理论及医药企业知识产权管理特征等进行分析的基础上,结合已有研究和我国医药企业知识产权管理具体实践,认为对医药企业的知识产权管理存在显著影响的有五个方面,分别为:知识产权管理平台建设、知识产权研发与运用、知识产权保护、知识产权经营及知识产权战略。在此基础上,构建了针对我国医药企业的知识产权管理绩效评价指标体系。进一步根据研究需要,本文选取了模糊综合评价法作为具体的评价方法,也在此基础上建立了医药企业知识产权管理绩效的评价模型。(2)选取医药行业中具有较高竞争力的健康元药业集团股份有限公司,运用本文构建的医药企业知识产权管理绩效评价模型进行实证评价研究。通过研究得出,即便是对于在医药行业百强榜上名列前茅的上市企业,其全过程的知识产权管理绩效也只是处于一般水平,只在知识产权管理的部分过程处于“较好”等级,而总体水平却差强人意。这说明我国医药企业对知识产权的管理有待加强,需要进一步改善医药企业的知识产权管理工作。
[Abstract]:With the development of knowledge economy, intellectual property has become the key of enterprise competition under the background of economic globalization. In order to better integrate into the globalization, improve the core competitiveness of enterprises to cope with the fierce market competition. It has become an urgent task to improve the intellectual property management level of enterprises. Based on the specific characteristics of intellectual property rights of pharmaceutical enterprises in China, this paper combines relevant theoretical research, on the one hand, to grasp intellectual property rights in a targeted manner. The relationship between intellectual property management and pharmaceutical enterprises; on the other hand, from the perspective of the whole process of intellectual property management, the performance evaluation index system of intellectual property management for pharmaceutical enterprises in China is established. The fuzzy comprehensive evaluation method is used to construct the model. Furthermore, the listed pharmaceutical sample enterprises in China are selected for empirical evaluation. The purpose of this paper is to provide a scientific and operable method for evaluating the intellectual property management performance of Chinese pharmaceutical enterprises. In order to promote the sustainable development of pharmaceutical enterprises in China, the author puts forward some reasonable opinions and suggestions to improve the intellectual property management of pharmaceutical enterprises in China. Based on the analysis of the relevant theories of performance evaluation and the characteristics of intellectual property management of pharmaceutical enterprises, combined with the existing research and the specific practice of intellectual property management of pharmaceutical enterprises in China, It is concluded that there are five aspects that have significant influence on the intellectual property management of pharmaceutical enterprises, namely, the construction of intellectual property management platform, the development and application of intellectual property rights, and the protection of intellectual property rights. The intellectual property management and intellectual property strategy. On this basis, the performance evaluation index system of intellectual property management for pharmaceutical enterprises in China is constructed. In this paper, the fuzzy comprehensive evaluation method is selected as the concrete evaluation method. On this basis, the evaluation model of intellectual property management performance of pharmaceutical enterprises is established. Using the intellectual property management performance evaluation model of pharmaceutical enterprises constructed in this paper to carry out empirical evaluation research. Through the research, it is concluded that, even for the top 100 listed companies in the pharmaceutical industry, The whole process of intellectual property management performance is only in the general level, only in part of the process of intellectual property management in the "better" level, However, the overall level is not satisfactory, which indicates that the management of intellectual property in Chinese pharmaceutical enterprises needs to be strengthened, and the management of intellectual property rights in pharmaceutical enterprises should be further improved.
【学位授予单位】：辽宁大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：F426.72;F273.1

【参考文献】